Arovella Therapeutics ASX: ALA

@arovella_therapeutics

Melbourne, Victoria

http://www.arovella.com

Biotechnology Research

Overview

About Arovella Therapeutics ASX: ALA

Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.

Headquarters

Melbourne, Victoria

Website

http://www.arovella.com

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Public Company

Founded

Specialties

Biotechnology, Advanced Cell Therapy, Oncology, iNKT Cell Therapy, Invariant natural killer T (iNKT) cell therapy platform, CAR engineering, blood cancers, and solid tumours